CDC Appoints New Director Amid Controversies
The Senate has confirmed Susan Monales as the new director of the Centers for Disease Control and Prevention (CDC). This appointment comes during a significant reform period initiated by Robert F. Kennedy Jr. at the Department of Health and Human Services (HHS). Monales, who is 50 years old, was confirmed on a party-line vote of 51 to 47, making her the second candidate appointed by President Trump.
A law enacted in 2023, known as the CDC Leadership Accountability Act, now mandates Senate confirmation for the CDC director. Monales is the first to undergo this process, as previous appointees typically took on the role without Senate approval.
Looking ahead, the Trump administration is planning to cut government budgets by nearly 50% in 2026, which could lead to the loss of hundreds of jobs. This has raised eyebrows among health professionals. Several have criticized Kennedy for allegedly violating agency protocols by modifying vaccine guidelines and dismissing important advisory board members.
There are, however, concerns surrounding the financial connections between healthcare professionals and pharmaceutical companies, which may lead to potential conflicts of interest.
Kennedy has removed all 17 members of the Advisory Committee on Vaccination Practices (ACIP), appointing new members of his choosing. It’s worth noting that CDC policy requires the director to formally endorse ACIP recommendations, yet Kennedy had previously taken on the responsibilities of the CDC director.
In a recent meeting, Kennedy’s newly formed ACIP voted to eliminate thimerosal—an organic mercury-based compound previously used as a preservative in flu vaccines. Although he approved this measure last week, he has not yet backed an additional recommendation for universal flu vaccinations.
Thimerosal is nearly 49% mercury. In 1999, the US Public Health Service and the American Academy of Pediatrics advised against its use in childhood vaccinations to lessen mercury exposure.
Additionally, Kennedy bypassed standard protocols by stating that HHS would refrain from recommending mRNA Covid-19 vaccines for healthy pregnant women and children.
Before her appointment, Monales lacked prior ties to the CDC, having served as deputy director of the Advanced Research Projects Bureau with two decades of federal service experience under her belt. Early in her career, she worked as a science and technology policy fellow, marking her entry into public service.
Trump appointed Monales after his initial candidate, former Florida GOP president Dave Weldon, did not gain enough support among Senate Republicans for the role.
During her confirmation hearing, Monales was questioned by a Democratic senator, emphasizing that “vaccines save lives” while asserting that there is no dependable scientific evidence connecting vaccines to autism. She managed to sidestep direct criticism of Kennedy and navigated the discussion tactfully.
